SCHEMBL25713782

SCHEMBL25713782

CC1(C)c2cc(C(F)(F)F)ccc2-c2c1c1c(c3ccccc23)OC(c2ccc(N3CCOCC3)cc2)(c2ccc3ccccc3c2)C=C1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PDK2 Q15119 2/20 0.33
PIK3CA P42336 1/20 0.32
NPSR1 Q6W5P4 2/20 0.31
GAA P10253 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
PRKDC P78527 1/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
LRRK2 Q5S007 1/20 0.30
THRB P10828 1/20 0.30
HPGD P15428 1/20 0.30
XBP1 P17861 1/20 0.30
RAF1 P04049 1/20 0.30
BRAF P15056 1/20 0.30
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25601559 0.96 PDK2 (0.32) ALDH1A1MAPTKDM4EPDK2PIK3CA
SCHEMBL25601561 0.95 PDK2 (0.33) ALDH1A1MAPTKDM4EPDK2PIK3CA
SCHEMBL25713626 0.95 CASR (0.31) MAPTKDM4EGAASLC6A2SLC6A4
SCHEMBL25845657 0.95 PDK2 (0.36) ALDH1A1MAPTKDM4EPDK2PIK3CA
SCHEMBL25601564 0.94 PDK2 (0.33) PDK2PIK3CALRRK2
SCHEMBL25601567 0.94 PDK2 (0.35) PDK2PIK3CALRRK2
SCHEMBL21681691 0.93 PDK2 (0.35) ALDH1A1MAPTKDM4EPDK2PIK3CA
SCHEMBL30658614 0.93 PDK2 (0.35) ALDH1A1MAPTKDM4EPDK2PIK3CA
SCHEMBL25601566 0.93 PIK3CA (0.32) ALDH1A1PDK2PIK3CASMN1; SMN2LRRK2
SCHEMBL26640227 0.92 PDK2 (0.34) ALDH1A1MAPTKDM4EPDK2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4270067-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND GLASSES Hoya Lens Thailand Ltd. (TH) 2023-11-01 EP disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed
EP-4198583-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES Hoya Lens Thailand Ltd. (TH) 2023-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 ALDH1A1 1091/4885MAPT 3015/4885KDM4E 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.